Roux-en-Y Gastric Bypass and Caloric Restriction but Not Gut Hormone-Based Treatments Profoundly Impact the Hypothalamic Transcriptome in Obese Rats.
Ulrich DischingerTobias HeckelThorsten BischlerJulia HasingerMalina KönigsrainerAngelika Schmitt-BöhrerChristoph OttoFassnacht MartinFlorian SeyfriedMohammed Khair HankirPublished in: Nutrients (2021)
Despite causing similar body weight changes compared to RYGB and BWM, PYY3-36 + liraglutide treatment does not impact hypothalamic gene expression. Whether this striking difference is favorable or unfavorable to metabolic health in the long term requires further investigation.